MedTrace Logo

Neuromuscular Inhibition Technique on Iliotibial Band Friction Syndrome

NCT06980324 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2025-05-20

No results posted yet for this study

Summary

The goal of this clinical trial is to find the effect of integrated neuromuscular inhibition technique for iliotibial band in iliotibial band friction syndrome on pain intensity level, pressure pain threshold, knee range of motion, knee function and knee angle . The main questions it aims to answer are:

* Is there an effect of integrated neuromuscular inhibition technique for iliotibial band on pain intensity level in iliotibial band friction syndrome?
* Is there an effect of integrated neuromuscular inhibition technique for iliotibial band on pressure pain threshold in iliotibial band friction syndrome?
* Is there an effect of integrated neuromuscular inhibition technique for iliotibial band on knee range of motion in iliotibial band friction syndrome?
* Is there an effect of integrated neuromuscular inhibition technique for iliotibial band on knee function in iliotibial friction syndrome? Is there an effect of integrated neuromuscular inhibition technique for iliotibial band on knee angle in iliotibial band friction syndrome?

Researchers will compare integrated neuromuscular inhibition technique to conventional physiotherapy to see if integrated neuromuscular inhibition technique works to treat iliotibial band syndrome.

Participants will:

* Take sessions for 2 weeks
* Visit the department 3 times per week

Conditions

  • Iliotibial Band Syndrome

Interventions

OTHER

integrated neuromuscular inhibition technique

integrated neuromuscular inhibition technique consists of: * ischemic compression * Positional release * Muscle energy technique

OTHER

conventional physical therapy treatment

Conventional physical therapy treatment: * Ultrasound * Hotpacks * Iliotibial band stretching * Static quadriceps and hamstring exercises

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • AMIR MO Saleh, Professor of Physical Therapy · Cairo University

  • Doaa RA Elazab, Assistant professor · Cairo University

  • Hassan HU Ahmed, Orthopedic Surgery Professor · Faculty of Medicine Banha University

  • Esraa TA Farouk, Physical therapist · Cairo University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-03-02
Primary Completion
2025-05-31
Completion
2025-07-31

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06980324 on ClinicalTrials.gov